• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

需要机械通气的非HIV患者肺炎死亡率的危险因素:一项回顾性病例系列研究。

Risk Factors for the Mortality of Pneumonia in Non-HIV Patients Who Required Mechanical Ventilation: A Retrospective Case Series Study.

作者信息

Kotani Toru, Katayama Shinshu, Miyazaki Yuya, Fukuda Satoshi, Sato Yoko, Ohsugi Koichi

机构信息

Department of Anesthesiology and Intensive Care Medicine, Tokyo Women's Medical University, Tokyo 162-8666, Japan.

出版信息

Biomed Res Int. 2017;2017:7452604. doi: 10.1155/2017/7452604. Epub 2017 May 8.

DOI:10.1155/2017/7452604
PMID:28567422
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5439059/
Abstract

BACKGROUND

The risk factors for the mortality rate of pneumonia (PCP) who required mechanical ventilation (MV) remained unknown.

METHODS

A retrospective chart review was performed of all PCP patients admitted to our intensive care unit and treated for acute hypoxemic respiratory failure to assess the risk factors for the high mortality.

RESULTS

Twenty patients without human immunodeficiency virus infection required mechanical ventilation; 19 received noninvasive ventilation; and 11 were intubated. PEEP was incrementally increased and titrated to maintain FIO as low as possible. No mandatory ventilation was used. Sixteen patients (80%) survived. Pneumothorax developed in one patient with rheumatoid arthritis (RA). Median PEEP level in the first 5 days was 10.0 cmHO and not associated with death. Multivariate analysis showed the association of incidence of interstitial lung disease and increase in serum KL-6 with 90-day mortality.

CONCLUSIONS

We found MV strategies to prevent pneumothorax including liberal use of noninvasive ventilation, and PEEP titration and disuse of mandatory ventilation may improve mortality in this setting. Underlying disease of interstitial lung disease was a risk factor and KL-6 may be a useful predictor associated with mortality in patients with RA. These findings will need to be validated in larger studies.

摘要

背景

需要机械通气(MV)的肺炎(PCP)患者死亡率的危险因素尚不清楚。

方法

对入住我们重症监护病房并因急性低氧性呼吸衰竭接受治疗的所有PCP患者进行回顾性病历审查,以评估高死亡率的危险因素。

结果

20例无人类免疫缺陷病毒感染的患者需要机械通气;19例接受无创通气;11例进行了气管插管。逐步增加呼气末正压(PEEP)并进行滴定,以保持尽可能低的吸入氧浓度(FIO)。未使用强制通气。16例患者(80%)存活。1例类风湿关节炎(RA)患者发生气胸。前5天的PEEP中位数为10.0cmH₂O,与死亡无关。多因素分析显示间质性肺疾病的发生率和血清KL-6升高与90天死亡率相关。

结论

我们发现预防气胸的MV策略包括广泛使用无创通气,PEEP滴定和不使用强制通气可能会改善这种情况下的死亡率。间质性肺疾病的基础疾病是一个危险因素,KL-6可能是与RA患者死亡率相关的有用预测指标。这些发现需要在更大规模的研究中得到验证。

相似文献

1
Risk Factors for the Mortality of Pneumonia in Non-HIV Patients Who Required Mechanical Ventilation: A Retrospective Case Series Study.需要机械通气的非HIV患者肺炎死亡率的危险因素:一项回顾性病例系列研究。
Biomed Res Int. 2017;2017:7452604. doi: 10.1155/2017/7452604. Epub 2017 May 8.
2
Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease.潜在肾功能不全:非移植性肾小球疾病免疫抑制患者发生耶氏肺孢子菌肺炎的关键危险因素。
Int Urol Nephrol. 2016 Nov;48(11):1863-1871. doi: 10.1007/s11255-016-1324-x. Epub 2016 Jun 28.
3
Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia.血清β-D-葡聚糖和KL-6水平在耶氏肺孢子菌肺炎中的临床应用价值
Intern Med. 2009;48(4):195-202. doi: 10.2169/internalmedicine.48.1680. Epub 2009 Feb 16.
4
Serial change in serum biomarkers during treatment of Non-HIV Pneumocystis pneumonia.治疗非 HIV 相关卡氏肺孢子菌肺炎过程中血清生物标志物的连续变化。
J Infect Chemother. 2019 Dec;25(12):936-942. doi: 10.1016/j.jiac.2019.05.007. Epub 2019 Jun 8.
5
Clinical impact of pneumothorax in patients with Pneumocystis jirovecii pneumonia and respiratory failure in an HIV-negative cohort.HIV 阴性人群中卡氏肺孢子菌肺炎合并呼吸衰竭患者气胸的临床影响。
BMC Pulm Med. 2022 Jan 8;22(1):7. doi: 10.1186/s12890-021-01812-z.
6
[Pneumocystis jiroveci pneumonia: Clinical characteristics and mortality risk factors in an Intensive Care Unit].[耶氏肺孢子菌肺炎:重症监护病房的临床特征及死亡风险因素]
Med Intensiva. 2015 Jan-Feb;39(1):13-9. doi: 10.1016/j.medin.2013.11.006. Epub 2014 Jan 31.
7
Survival following mechanical ventilation for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: a different perspective.获得性免疫缺陷综合征患者卡氏肺孢子虫肺炎机械通气后的生存情况:一个不同的视角。
Am J Med. 1989 Oct;87(4):401-4. doi: 10.1016/s0002-9343(89)80821-6.
8
Clinical Manifestations and Prognostic Factors of Pneumocystis jirovecii Pneumonia without HIV.无人类免疫缺陷病毒(HIV)的耶氏肺孢子菌肺炎的临床表现及预后因素
Chemotherapy. 2017;62(6):343-349. doi: 10.1159/000477332. Epub 2017 Jul 19.
9
Acute exacerbation of interstitial pneumonia associated with rheumatoid arthritis during the course of treatment for Pneumocystis jirovecii pneumonia: a case report.耶氏肺孢子菌肺炎治疗过程中并发类风湿关节炎相关间质性肺炎急性加重:一例报告
BMC Res Notes. 2016 Apr 26;9:240. doi: 10.1186/s13104-016-2052-0.
10
Retrospective review of Pneumocystis jirovecii pneumonia over two decades.对卡氏肺孢子菌肺炎长达二十年的回顾性研究。
Int J STD AIDS. 2009 Mar;20(3):200-1. doi: 10.1258/ijsa.2008.008198.

引用本文的文献

1
Association between the cumulative dose of glucocorticoids before the development of pneumonia and death in patients receiving long-term glucocorticoids: a secondary analysis based on a Chinese cohort study.长期接受糖皮质激素治疗的患者在发生肺炎前糖皮质激素累积剂量与死亡之间的关联:基于一项中国队列研究的二次分析
Front Med (Lausanne). 2023 Jul 20;10:1175855. doi: 10.3389/fmed.2023.1175855. eCollection 2023.
2
Risk factors of pneumothorax and pneumomediastinum in COVID-19: a matched case-control study.新型冠状病毒肺炎并发气胸和纵隔气肿的危险因素:一项病例对照研究。
BMC Infect Dis. 2023 Mar 7;23(1):137. doi: 10.1186/s12879-023-08104-3.
3
Development and Validation of a Diagnostic Nomogram for Pneumonia in Non-HIV-Infected Pneumonia Patients Undergoing Oral Glucocorticoid Treatment.接受口服糖皮质激素治疗的非HIV感染肺炎患者肺炎诊断列线图的开发与验证
Infect Drug Resist. 2023 Feb 4;16:755-767. doi: 10.2147/IDR.S398850. eCollection 2023.
4
Risk factors for Pneumocystis pneumonia with acute respiratory failure among kidney transplant recipients.肾移植受者合并急性呼吸衰竭的卡氏肺孢子菌肺炎的危险因素。
BMC Nephrol. 2023 Feb 9;24(1):31. doi: 10.1186/s12882-023-03071-y.
5
Diagnostic Value of Bronchoalveolar Lavage Fluid Metagenomic Next-Generation Sequencing in Pneumonia in Non-HIV Immunosuppressed Patients.支气管肺泡灌洗液宏基因组下一代测序在非 HIV 免疫抑制患者肺炎中的诊断价值。
Front Cell Infect Microbiol. 2022 Apr 8;12:872813. doi: 10.3389/fcimb.2022.872813. eCollection 2022.
6
Clinical impact of pneumothorax in patients with Pneumocystis jirovecii pneumonia and respiratory failure in an HIV-negative cohort.HIV 阴性人群中卡氏肺孢子菌肺炎合并呼吸衰竭患者气胸的临床影响。
BMC Pulm Med. 2022 Jan 8;22(1):7. doi: 10.1186/s12890-021-01812-z.
7
Adhesins in the virulence of opportunistic fungal pathogens of human.黏附素在人类机会性真菌病原体毒力中的作用
Mycology. 2021 Jul 5;12(4):296-324. doi: 10.1080/21501203.2021.1934176. eCollection 2021.
8
Estimation of treatment and prognostic factors of pneumocystis pneumonia in patients with connective tissue diseases.结缔组织病患者肺孢子菌肺炎的治疗和预后因素评估。
RMD Open. 2021 Mar;7(1). doi: 10.1136/rmdopen-2020-001508.
9
Aetiology and prognostic risk factors of mortality in patients with pneumonia receiving glucocorticoids alone or glucocorticoids and other immunosuppressants: a retrospective cohort study.单独接受糖皮质激素或糖皮质激素与其他免疫抑制剂治疗的肺炎患者死亡的病因及预后风险因素:一项回顾性队列研究
BMJ Open. 2020 Oct 27;10(10):e037419. doi: 10.1136/bmjopen-2020-037419.
10
Lower Mortality Associated With Adjuvant Corticosteroid Therapy in Non-HIV-Infected Patients With Pneumonia: A Single-Institution Retrospective US Cohort Study.非HIV感染肺炎患者辅助性皮质类固醇治疗与较低死亡率的关系:一项单机构回顾性美国队列研究
Open Forum Infect Dis. 2020 Aug 13;7(9):ofaa354. doi: 10.1093/ofid/ofaa354. eCollection 2020 Sep.

本文引用的文献

1
Prognosis of pneumocystis pneumonia complicated in patients with rheumatoid arthritis (RA) and non-RA rheumatic diseases.类风湿关节炎(RA)及非 RA 风湿性疾病合并肺孢子菌肺炎患者的预后。
Mod Rheumatol. 2012 Aug;22(4):509-14. doi: 10.1007/s10165-011-0523-7. Epub 2011 Oct 5.
2
Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases.TNF 靶向治疗引起或加重的间质性肺疾病:122 例分析。
Semin Arthritis Rheum. 2011 Oct;41(2):256-64. doi: 10.1016/j.semarthrit.2010.11.002. Epub 2011 Feb 1.
3
Pneumocystis jirovecii Pneumonia.肺孢子菌肺炎。
Infect Dis Clin North Am. 2010 Mar;24(1):107-38. doi: 10.1016/j.idc.2009.10.010.
4
Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host.肾移植受者中耶氏肺孢子菌肺炎的暴发:耶氏肺孢子菌对易感宿主具有传染性。
Transplantation. 2009 Aug 15;88(3):380-5. doi: 10.1097/TP.0b013e3181aed389.
5
Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia.血清β-D-葡聚糖和KL-6水平在耶氏肺孢子菌肺炎中的临床应用价值
Intern Med. 2009;48(4):195-202. doi: 10.2169/internalmedicine.48.1680. Epub 2009 Feb 16.
6
Acute respiratory failure due to Pneumocystis pneumonia: outcome and prognostic factors.卡氏肺孢子菌肺炎所致急性呼吸衰竭:结局与预后因素
Int J Infect Dis. 2009 Jan;13(1):59-66. doi: 10.1016/j.ijid.2008.03.027. Epub 2008 Jun 24.
7
Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection.合并或未合并HIV感染的重症肺孢子菌肺炎患者的重症监护管理及预后
Crit Care. 2008;12(1):R28. doi: 10.1186/cc6806. Epub 2008 Jan 25.
8
Pneumocystis pneumonia associated with infliximab in Japan.日本与英夫利昔单抗相关的肺孢子菌肺炎
N Engl J Med. 2007 Nov 1;357(18):1874-6. doi: 10.1056/NEJMc070728.
9
Serum indicators for the diagnosis of pneumocystis pneumonia.用于诊断肺孢子菌肺炎的血清指标。
Chest. 2007 Apr;131(4):1173-80. doi: 10.1378/chest.06-1467.
10
Evaluation of Pneumocystis pneumonia infection risk factors in patients with connective tissue disease.结缔组织病患者肺孢子菌肺炎感染危险因素的评估
Mod Rheumatol. 2006;16(5):282-8. doi: 10.1007/s10165-006-0502-6.